胆固醇性肝病:现代治疗方法
Bridgette B McNally1, Elizabeth J Carey1
1Mayo Clinic Arizona, Department of Gastroenterology & Hepatology, Division of Hepatology, Phoenix, Arizona, USA.
Expert review of gastroenterology & hepatology
|February 26, 2025
概括
管理自身免疫胆固醇性肝脏疾病的最新进展,如初级胆道胆固醇炎 (PBC) 和初级硬化胆固醇炎 (PSC),包括超出乌尔索二氧化醇酸 (UDCA) 的新疗法和正在进行的PSC临床试验.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 自免疫性肝脏疾病 自免疫性肝脏疾病
- 胆固醇性肝脏疾病 胆固醇性肝脏疾病
背景情况:
- 胆固醇性肝病会损害胆汁流动,导致疲劳,黄和.
- 原发性胆道胆炎 (PBC) 和原发性硬化胆炎 (PSC) 是一种自身免疫胆状况.
- 目前对PBC的治疗包括ursodeoxycholic acid (UDCA),与obeticholic acid (OCA) 作为次优反应的选择.
研究的目的:
- 审查最近在治疗自身免疫胆固醇性肝病方面的进展.
- 为突出初级胆道胆炎 (PBC) 的新兴疗法.
- 讨论当前的治疗环境和对原发性硬化性胆道炎 (PSC) 的持续研究.
主要方法:
- 对PBC和PSC管理的当前文献和临床试验数据的审查.
- 专注于药理干预和新的治疗目标.
- 对治疗反应和新兴药物类别的分析.
主要成果:
- Ursodeoxycholic 酸 (UDCA) 仍然是PBC的主要治疗方法,而 obeticholic 酸 (OCA) 是第二线的选择.
- 纤维酸对PBC有希望,但缺乏FDA批准; 过氧体增殖器激活受体激活剂 (PPAR) 是一种新的口服药物类别.
- 皮质胆汁酸载体 (IBAT) 抑制剂正在研究与PBC相关的;对于PSC没有批准的治疗方法,但对抗生素,PPAR和免疫调节剂正在进行试验.
结论:
- 对PBC和PSC的新型治疗方法的持续研究至关重要.
- 预计在未来5-10年内,这两种疾病的替代管理策略将出现.
- 不断发展的治疗环境为改善胆固醇性肝病患者的治疗结果提供了希望.
更多相关视频
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
509
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
509
Chronic Pancreatitis II: Collaborative Care
56
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
56
Hepatic Drug Excretion: Enterohepatic Cycling
918
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
918
Hepatic Drug Excretion: Influencing Factors
78
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
78
Hepatic Drug Clearance: Role of Transporters
32
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
32
Cholesterol: Significance and Regulation
496
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
496


